…ed favorable CHS-114 mediated anti-tumor remodeling.Conclusions CHS-114 administration to HNSCC patients demonstrates selective depleti…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 85 of 2459…Background Diffuse midline glioma (DMG) is a fatal tumor characterized by H3K27M mutation that is…
…esponses including autophagy (figure 2C). Finally, single agent encorafenib was administered in the 3rd and 4th line in two patients with l…
…Background Ovarian cancer is one of the most prevalent gynecologic malignancies worldwide…
…pment of chemerin-based immunotherapies to improve responses in prostate cancer, particularly in tumors otherwise resistant to immunotherapy.Re…
…of specialist review, acute assessment and discharge bundle. In COPD, severe mental health and dementia/cognitive impairment was ass…
…bations before or after LT-NIV initiation.Conclusion Coexisting Bronchiectasis increases the risk of infective exacerbations in patients with …
…Introduction and Objectives Obstructive sleep apnoea (OSA) causes significant symptom burden to patients and is asso…
… Chi 2=6.6, p=0.0092).In Cox proportional hazard modelling, low testosterone increased risk of death (HR=2.23, p=0.038) when accounting for …
…on were compared between those receiving high-efficacy therapy (fingolimod, cladribine, monoclonal antibodies) vs. other/no therapy. Margi…